Fusion Pharmaceuticals Inc.

Market

Fusion Pharmaceuticals Inc [FUSN] Is Currently 0.00 below its 200 Period Moving Avg: What Does This Mean?

Fusion Pharmaceuticals Inc [NASDAQ: FUSN] price plunged by 0.00 percent to reach at $0.0. The company report on April 9, 2024 at 4:05 PM that Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual

Companies

Fusion Pharmaceuticals Inc [FUSN] Revenue clocked in at $2.21 million, up 120.40% YTD: What’s Next?

Fusion Pharmaceuticals Inc [NASDAQ: FUSN] gained 99.06% on the last trading session, reaching $21.18 price per share at the time. The company report on March 19, 2024 at 3:00 AM that Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat

Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc [FUSN] Is Currently 0.00 below its 200 Period Moving Avg: What Does This Mean?

Fusion Pharmaceuticals Inc [FUSN] Revenue clocked in at $2.21 million, up 120.40% YTD: What’s Next?

Quick Links

Categories

Get The Best Stocks To Trade Every Day!